Hepatitis B Vaccine Study (Sci-B-Vac-001)

This study is a double-blind randomized controlled trial designed to establish the non-inferiority of Sci-B-Vac compared to Engerix-B® in adults ≥ 18 years old and the superiority of Sci-B-Vac™ compared to Engerix-B® in adults ≥ 45 years old. Study subjects will be randomized 1:1 to receive either a total of 3 injections of Sci-B-Vac™ or 3 injections of Engerix-B® intra-muscularly (IM) on Days 0, 28, and 168.


Register Today!

Trial Information

Start DateMarch 2018
End DateApril 2019
Trial Duration1 Year
Number of Visits6 In-Person
Lead CRCAdam Pawluch

For additional information
on this trial contact: